ABCG2 and metabolic dysfunction-associated steatotic liver disease: Taken together, these observations may provide an early evidence supporting the role of genetic alterations in the lipid metabolism pathways including ABC transporters and their central regulators in the MASLD pathogenesis and DD symptoms presence.